1. Zhang, L, Sahar, A M, Li, C, Feng, W, Hameed, Y. 2022. A detailed multi-omics analysis of GNB2 gene in human cancers. In Brazilian journal of biology = Revista brasleira de biologia, 84, e260169. doi:10.1590/1519-6984.260169. https://pubmed.ncbi.nlm.nih.gov/35730811/
2. Tan, Yonghong, Wang, Qiong, Zhao, Baisong, She, Yingjun, Bi, Xiaobao. 2016. GNB2 is a mediator of lidocaine-induced apoptosis in rat pheochromocytoma PC12 cells. In Neurotoxicology, 54, 53-64. doi:10.1016/j.neuro.2016.03.015. https://pubmed.ncbi.nlm.nih.gov/27018092/
3. Shi, Yingxiang, Wang, Jing, Tao, Shuang, Shi, Yurong, Yang, Qingling. 2022. miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway. In Cellular signalling, 103, 110566. doi:10.1016/j.cellsig.2022.110566. https://pubmed.ncbi.nlm.nih.gov/36539001/
4. Fukuda, Tokiko, Hiraide, Takuya, Yamoto, Kaori, Ogata, Tsutomu, Saitsu, Hirotomo. 2019. Exome reports A de novo GNB2 variant associated with global developmental delay, intellectual disability, and dysmorphic features. In European journal of medical genetics, 63, 103804. doi:10.1016/j.ejmg.2019.103804. https://pubmed.ncbi.nlm.nih.gov/31698099/
5. Kayser, Anne, Dittmann, Sven, Hamidi, Jassin, Hansen, Arne, Schulze-Bahr, Eric. 2024. Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A). In Stem cell research, 78, 103446. doi:10.1016/j.scr.2024.103446. https://pubmed.ncbi.nlm.nih.gov/38776645/
智鼠故事 
